Clinical Trial Update: Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE- [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating green tea extract to minimize risk of metachronous colorectal adenomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Serrated Adenomas
• Colorectal Tubular Adenomas
• Colorectal Tubulovillous Adenomas
• Colorectal Villous Adenomas

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Colorectal Serrated Adenomas, Colorectal Tubular Adenomas | Phase 2 | Status: COMPLETED